Document gEg4GYDLb5VK9BLdov3Z4vbGV

Interoffice Communication To F. Kennedy (conoco) CHEMICALS. REdtAECH MAft 17 !^3 K C From Date W. D. Broddle March 14, 1980 Vi R B e A1CL Subject Meeting of Chemical Manufacturers Association's Vinyl Chloride LM Project Panel and Research Coordinators As requested, I attended the above meeting held at the CMA offices in Washington, D.C., March 4, 1980. Attachment 1 shows the list of at tendees. The first item discussed concerned the NIH-sponsored conference on VC and PVC to be held March 20-21, 1980 (Attachment 2). Reservations should be made IMMEDIATELY. Unfortunately, I cannot attend this conference but would appreciate any follow-up (handouts, notes, etc). Personnel of CMA member companies will be some of the speakers at the conference. Previously, OSHA had requested additional health and manufacturing data but has extended the deadline to May, 1980. This may allow the EPA and OSHA to use results obtained at the conference for setting a new future exposure standard. OSHA and NIOSH are also developing a CRITERIA DOCU MENT (VC and/or PVC?). Discussion then centered on epidemiological studies completed or pro posed by Environmental Health Associates (Attachments 3 and 4). Deci sions made were as follows: 1. Lines 16-21, page 2, of Attachment 3 will be changed to that in Attachment 4, lines 16-21, page 4, but OMIT the last sentence in either paragraph. 2. Panel Survey Inquiry (Attachment 4): a. Item 4.2: Change to read, "We are interested in financially sponsoring a thorough case-control evaluation and a clinical examination of each brain tumor." b. Item 4.4: It was pointed out that Plan B is an attempt to determine if one can separate the toxicity of VCM vs. PVC^ t vs. EDC vs. Miscellaneous toxicity. c. Items 4.4 and 4.5: Omit and consider at a future date. d. Item 5: Omit. DTH 000017908 F. Kennedy Page 2 March 14, 1980 3. Environmental Health Associates (EHA) will be asked to prepare financial estimates for comparing Industrial exposure to VCM vs. PVC emulsion-dispersions (excluding latex) vs. all other VCM-PVC workers as to mortality and cancer (cost will hopefully be less than $10,000). Additional discussion involved: 1. EHA will be asked, at no additional cost, to explain the exposure deficiencies for the 3300 employees (Attachment 4). 2. The CMA legal department has not yet prepared a status report of the IBT animal toxicology studies. 3. CMA will re-submit all VC-PVC data and any input provided by the SPI to OSHA as requested recently. 4. SPI would like to publish a review on all VC-PVC studies. Flynt, I enjoyed participating in this meeting, and please inquire as to any questions you may have. W. D. Broddle jj Enc CC: D. Kuhn DTH 000017909